Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Foxwell

Showing results (141-150 of 346) with videos related to

Pageof 35
Sort By:
Annals of the Rheumatic Diseases|March 14, 2002
High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approachB M Foxwell, S Yoshimura, J Bondeson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2006
Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvantE Andreakos, R O Williams, J Wales, et al.
Expert Opinion on Biological Therapy|July 16, 2005
Pseudomonas aeruginosa: the potential to immunise against infectionE Sedlak-Weinstein, A W Cripps, J M Kyd, et al.
Transplantation Proceedings|April 1, 1988
Biologic significance of cyclosporine metabolitesB Ryffel, B M Foxwell, M J Mihatsch, et al.
Toxicology|January 1, 1985
The use of anti-ricin antibodies to protect mice intoxicated with ricinB M Foxwell, S I Detre, T A Donovan, et al.
Journal of Cell Science|January 23, 2003
VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2Serafim Kiriakidis, Evangelos Andreakos, Claudia Monaco, et al.
Annals of the Rheumatic Diseases|October 9, 2003
Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agentsB Foxwell, E Andreakos, F Brennan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
A late, prolonged activation of the phosphatidylinositol 3-kinase pathway is required for T cell proliferationFerdinand V Lali, James Crawley, Derek A McCulloch, et al.
Biochemical Pharmacology|March 3, 1992
Covalent binding of cyclosporine inhibits irreversibly T-lymphocyte activationB Ryffel, G Woerly, V F Quesniaux, et al.
Cognition|January 23, 2024
Individual differences in internal models explain idiosyncrasies in scene perceptionGongting Wang, Matthew J Foxwell, Radoslaw M Cichy, et al.
Pageof 35

Showing results (141-150 of 346) with videos related to

Sort By:
Pageof 35
Annals of the Rheumatic Diseases|March 14, 2002
High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approachB M Foxwell, S Yoshimura, J Bondeson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2006
Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvantE Andreakos, R O Williams, J Wales, et al.
Expert Opinion on Biological Therapy|July 16, 2005
Pseudomonas aeruginosa: the potential to immunise against infectionE Sedlak-Weinstein, A W Cripps, J M Kyd, et al.
Transplantation Proceedings|April 1, 1988
Biologic significance of cyclosporine metabolitesB Ryffel, B M Foxwell, M J Mihatsch, et al.
Toxicology|January 1, 1985
The use of anti-ricin antibodies to protect mice intoxicated with ricinB M Foxwell, S I Detre, T A Donovan, et al.
Journal of Cell Science|January 23, 2003
VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2Serafim Kiriakidis, Evangelos Andreakos, Claudia Monaco, et al.
Annals of the Rheumatic Diseases|October 9, 2003
Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agentsB Foxwell, E Andreakos, F Brennan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
A late, prolonged activation of the phosphatidylinositol 3-kinase pathway is required for T cell proliferationFerdinand V Lali, James Crawley, Derek A McCulloch, et al.
Biochemical Pharmacology|March 3, 1992
Covalent binding of cyclosporine inhibits irreversibly T-lymphocyte activationB Ryffel, G Woerly, V F Quesniaux, et al.
Cognition|January 23, 2024
Individual differences in internal models explain idiosyncrasies in scene perceptionGongting Wang, Matthew J Foxwell, Radoslaw M Cichy, et al.
Pageof 35